Compare HYI & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | HYI | MSLE |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Investment Managers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.2M | 154.6M |
| IPO Year | 2010 | 2007 |
| Metric | HYI | MSLE |
|---|---|---|
| Price | $10.16 | $9.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 61.4K | 24.5K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | ★ 9.59% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.10 | $5.44 |
| 52 Week High | $12.12 | $13.39 |
| Indicator | HYI | MSLE |
|---|---|---|
| Relative Strength Index (RSI) | 30.95 | 47.80 |
| Support Level | N/A | $8.88 |
| Resistance Level | $10.66 | $9.75 |
| Average True Range (ATR) | 0.09 | 0.52 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 36.75 | 34.62 |
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.